Dipna Pharmachem Rights Issue 2024 vs Magnum Ventures Rights Issue 2024

Comparison between Dipna Pharmachem Rights Issue 2024 and Magnum Ventures Rights Issue 2024.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Dipna Pharmachem Rights Issue 2024 and Magnum Ventures Rights Issue 2024. Dipna Pharmachem Rights Issue 2024 is listed on BSE while Magnum Ventures Rights Issue 2024 is listed on BSE, NSE.

 Dipna Pharmachem Ltd.Magnum Ventures Limited
LogoDipna Pharmachem Rights Issue 2024 LogoMagnum Ventures Rights Issue 2024 Logo
Listing AtBSEBSE, NSE
Terms of Payment

Full amount of Rs. 10/- per Equity share is payable on application by Eligible Equity shareholders.

Issue Price of Rs.54/- per Rights Equity Share (including premium of Rs.44/- per Rights Equity Share) shall be payable on Application.

Entitlement13 Rights Equity Share(s) for every 12 fully paid-up Equity Shares held on Record Date2 Rights Equity Share(s) for every 11 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarBigshare Services Pvt.Ltd.MAS Services Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Dipna Pharmachem Rights Issue 2024 rights issue is ₹12.97 Crores, whereas Magnum Ventures Rights Issue 2024 rights issue size is ₹48.92 Crores.

 Dipna Pharmachem Ltd.Magnum Ventures Limited
Issue Size1,29,67,500 shares90,59,433 shares
Issue Size (Amount)₹12.97 Crores₹48.92 Crores
Issue Price₹10 per share₹54 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Dipna Pharmachem Rights Issue 2024 is Feb 12, 2024 while record date of Magnum Ventures Rights Issue 2024 is Jan 25, 2024.

 Dipna Pharmachem Ltd.Magnum Ventures Limited
Record DateFeb 12, 2024Jan 25, 2024
Credit of Rights EntitlementsFeb 19, 2024
Bid/Offer Opens OnFeb 26, 2024Feb 07, 2024
Renunciation of Rights EntitlementsMar 04, 2024Feb 16, 2024
Bid/Offer Closes OnMar 20, 2024Feb 27, 2024
Deemed Date of AllotmentMar 14, 2024Mar 05, 2024
Credit DateMar 15, 2024Mar 06, 2024
Listing DateMar 18, 2024Mar 11, 2024

Financials details

Comparison of Dipna Pharmachem Rights Issue 2024 and Magnum Ventures Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Dipna Pharmachem Ltd.Magnum Ventures Limited
Financial

Dipna Pharmachem Ltd. Financial Information (Restated)

Dipna Pharmachem Ltd.'s revenue increased by 37.34% and profit after tax (PAT) dropped by -21.85% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 2022
Assets77.5636.23
Revenue99.9372.77
Profit After Tax0.911.17
Reserves and Surplus12.391.70
Amount in ₹ Crore

Magnum Ventures Limited Financial Information (Restated)

Magnum Ventures Limited's revenue increased by 40.38% and profit after tax (PAT) rose by 1276.58% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended30 Sep 202331 Mar 202331 Mar 202231 Mar 2021
Assets1,042.72314.97315.10
Revenue465.50331.60182.41
Profit After Tax48.3970.865.151.34
Net Worth600.68583.94-51.17-56.73
Reserves and Surplus541.84-88.77-94.33
Total Borrowing167.18166.12273.61294.48
Amount in ₹ Crore

Compare with others

Compare:

Dipna Pharmachem Rights Issue 2024 Vs Magnum Ventures Rights Issue 2024